New heart valve procedure could help patients with leaky aortic valve

NCT ID NCT06818084

Recruiting now Disease control Sponsor: Ruijin Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to replace the aortic valve in people with severe aortic regurgitation (a leaky heart valve). About 180 patients will get either the new VitaFlow valve or another device through a tube in the leg. The goal is to see if the new valve is safe and effective at reducing death, stroke, and hospital readmissions over one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aortic Valve Disease aortic valve disorder aortic valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC REGURGITATION AORTIC VALVE DISEASES TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)

Contacts and locations

Locations

Changhai Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200433, China
Ruijin hospital, Shanghai JiaoTong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, 200025, China
Shanghai Chest Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200030, China
Zhongshan Hospital, Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.